AIDS Seminar
Qualitative and Mixed Methods in Implementation Science: Finding the Right Balance
Tuesday, February 13, 10:30-11:30am
Deborah Padgett, PhD, MPH - NYU Silver
NYU Meyers, 433 First Ave, Room 202
Find more information HERE.


ICAP Grand Round Webinar
Updates on HIV Self Testing
Tuesday, January 23, 9:00am
Rachel Baggaley, MD, MSc & Cheryl Johnson, MA - WHO
Find more information HERE.

NYU Population Health Research Seminar
Opioid Disorder Treatments and Comparative Effectiveness: The X:BOT Trial and Current Large RCTs among Community and Correctional Populations
Wednesday, January 24, 12:00-1:00pm
Joshua D Lee MD, MSc - NYU Langone Health
NYU Translational Research Building, 227 E 30th St, Room 120
Find more information HERE.

NYU Population Health Grand Rounds
Challenges and Opportunities for Health Disparities Research
Thursday, January 25, 9:00-10:00am
Ana V Diez Roux, MD, PhD, MPH - Drexel University
NYU Translational Research Building, 227 E 30th St, Room 120
Find more information HERE.

Free Naloxone Training
Be Prepared to Save a Life!
Wednesday, January 31, 12:00-1:00pm
Janie Simmons, EdD - NDRI
NDRI-USA, 71 West 23rd Street, 4th Floor
Find more information HERE.

NYU Meyers Pless Talk Lunch Series
Getting SMART About Adaptive Interventions in Youth Mental Health
Thursday, February 8, 11:15am–12:30pm
Daniel Almirall, PhD - University of Michigan
Lunch will be provided at 11:15am
Please email to RSVP by January 30


Insurance-based Data-to-Care Strategy to (re-)Engage People Living with HIV Infection to Care and (re-)Start Antiretroviral Therapy
This announcement requests applications to develop and implement a novel strategy that uses insurance claims data to identify persons with a diagnosis of HIV who do not have ARV prescriptions. This could include those who 1) never had ARV prescriptions, or 2) have not had an ARV prescription for an extended period (e.g. greater than 6 months).


Health Services and Economic Research on the Prevention and Treatment of Drug, Alcohol, and Tobacco Abuse (R01 Clinical Trial Optional)


Rajan S, Ruggles KV, Guarino H, & Mateu-Gelabert P (2018) Heroin use and drug injection among youth also misusing prescription drugs. American Journal of Health Behavior, 42, 144-155. Find the abstract on the publisher's website HERE.

Vasylyeva TI, Liulchuk M, Friedman SR, Sazonova I, Faria NR, Katzourakis A, Babii N, Scherbinska A, Thézé J, Pybus OG, Smyrnov P, Mbisa JL, Paraskevis D, Hatzakis A, & Magiorkinis G (2018) Molecular epidemiology reveals the role of war in the spread of HIV in Ukraine. Proceedings of the National Academy of Sciences, doi: 10.1073/pnas.1701447115. Find the abstract on the publisher's website HERE.

Weiss JJ, Prieto S, Brau N, Dieterich DT, Marcus SM, Stivala A, & Gorman JM (2018) Multimethod assessment of baseline depression and relationship to hepatitis C treatment discontinuation. International Journal of Psychiatry in Medicine, doi: 10.1177/0091217417749796. Find the abstract on the publisher's website HERE.

Zule WA, Pande PG, Otiashvili D, Bobashev GV, Friedman SR, Gyarmathy VA, & Des Jarlais DC (2018) Options for reducing HIV transmission related to the dead space in needles and syringes. Harm Reduction Journal, 15, 3. Find the abstract on the publisher's website HERE.


The deadline for applications has been extended until January 24 for the Interdisciplinary Research Training Institute on Hispanic Drug Abuse (IRTI) program at the University of Southern California. The program is designed to promote the career development of pre-doctoral, post-doctoral and early career scientists interested in conducting research on drug abuse among Hispanics. The IRTI aims to ensure a formal support infrastructure for fellows to present, publish, and acquire funding for NIH research. Fellows in the program have access to the expertise of leading NIDA researchers and will receive training on topics specific to the socio-behavioral and bio-medical areas of Hispanic Drug Abuse. Find more information HERE.

Housing and HIV Research Summit
Structural Interventions and Ending the Epidemic
August 1-3, Washington, DC
Abstracts are being accepted through March 18